Release Date: 30/01/09 09:50 Summary: EFG Board Composition Changes Price Sensitive: No Download Document 28.77KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%